Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 185

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 185
---
. Our office holders are currently covered by a directors and officers’ liability insurance
policy. We intend to obtain a new policy that insures our officers and directors against the cost of defense, settlement or payment of
a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors. We are not aware of
any pending or threatened litigation or proceeding involving any of our directors or officers in which indemnification is sought, nor
are we aware of any pending or threatened litigation that may result in claims for indemnification by any director or officer.

We have entered and will
enter into agreements with each of our directors and executive officers exculpating them, to the fullest extent permitted by Israeli
law, from liability to us for damages caused to us as a result of a breach of duty of care, and undertaking to indemnify them to the
fullest extent permitted by the Israeli law. The insurance is subject to our discretion depending on its availability, effectiveness
and cost. Effective as of the consummation of this offering, the maximum amount set forth in such agreements is (1) with respect to indemnification
in connection with a public offering of our securities, the gross proceeds raised by us and/or any selling shareholder in such public
offering, and (2) with respect to all permitted indemnification, the greater of (i) an amount equal to 25% of our shareholders’
equity, based on our most recent financial statements made publicly available before the date on which the indemnity payment is made
and (ii) $20 million. In the opinion of the SEC, indemnification of directors and executive officers for liabilities arising under the
Securities Act however, is against public policy and therefore unenforceable.

A shareholder’s investment
may be adversely affected to the extent we pay the costs of settlement and damage awards against officers and directors pursuant to these
indemnification provisions. We believe that these provisions, the insurance and the indemnity agreements are necessary to attract and
retain talented and experienced officers and directors.

<div align='center'>112</div>

Equity Incentive Plan

2009 Option Plan

We adopted our 2009 Option
Plan, or 2009 Plan, in January 2009 and it is scheduled to expire in December 2029. The 2009 Plan provides for the grant of options to
our employees, directors, officers, consultants, advisors, suppliers, and any other person or entity whose services are considered valuable